Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Thomas J. Monroe"'
Autor:
Han-Mo Koo, George F. Vande Woude, Gabriela Bedolla, Alan T. Davis, Matthew W. Van Brocklin, Phyllis Stein, Kimberly J. Truszkowski, Michelle R. Bassett, Connie M. Szczepanek, Kathleen J. Yost, Timothy J. O'Rourke, Thomas J. Monroe, Alan D. Campbell, Charles R. Luttenton, Patrick J. Richardson, Craig P. Webb, Marianne K. Melnik
Supplementary Table 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c864040888e732f9c20c2310c5c261
https://doi.org/10.1158/1535-7163.22485188
https://doi.org/10.1158/1535-7163.22485188
Autor:
Han-Mo Koo, George F. Vande Woude, Gabriela Bedolla, Alan T. Davis, Matthew W. Van Brocklin, Phyllis Stein, Kimberly J. Truszkowski, Michelle R. Bassett, Connie M. Szczepanek, Kathleen J. Yost, Timothy J. O'Rourke, Thomas J. Monroe, Alan D. Campbell, Charles R. Luttenton, Patrick J. Richardson, Craig P. Webb, Marianne K. Melnik
Prior studies suggest that tumor cell lines harboring RAS mutations display remarkable sensitivity to gemcitabine and etoposide. In a phase II clinical trial of patients with locally advanced or metastatic pancreatic cancer, we evaluated the response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac05d7f09bbf7f596f622d484a34674
https://doi.org/10.1158/1535-7163.c.6531824.v1
https://doi.org/10.1158/1535-7163.c.6531824.v1
Autor:
Han-Mo Koo, George F. Vande Woude, Gabriela Bedolla, Alan T. Davis, Matthew W. Van Brocklin, Phyllis Stein, Kimberly J. Truszkowski, Michelle R. Bassett, Connie M. Szczepanek, Kathleen J. Yost, Timothy J. O'Rourke, Thomas J. Monroe, Alan D. Campbell, Charles R. Luttenton, Patrick J. Richardson, Craig P. Webb, Marianne K. Melnik
Supplementary Form 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caef588d4459fa29ca578f040067ac9
https://doi.org/10.1158/1535-7163.22485191.v1
https://doi.org/10.1158/1535-7163.22485191.v1
Autor:
Patricia I. Botma, Sandi L. Talbott, Gerald L. Feldman, Jin Fang, Thomas W. Prior, Fatimah A. Nahhas, Thomas J. Monroe, Pamela J. Snyder
Publikováno v:
Genetic Testing and Molecular Biomarkers. 16:187-192
Fragile X syndrome (FXS) is caused by the absence of a functional fragile X mental retardation protein (FMRP). In most cases, the molecular mutation is an expansion and consequent methylation of the CGG trinucleotide repeat in the 5' end of the FMR1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112288f15696c23b406f57b58ff760bf
https://doi.org/10.1089/gtmb.2011.0128
https://doi.org/10.1089/gtmb.2011.0128
Autor:
Cassandra K. Runke, Karen S. Metzler, Beth A. Pitel, Thomas J. Monroe, Nicole L. Hoppman, Yang Cao, Renee M. Olson, Julie Jesiolowski, Cherisse A. Marcou
Publikováno v:
Cancer Genetics. 208:357
Chromosomal microarray (CMA) is widely used to detect and refine chromosome abnormalities in both congenital and neoplastic cases. Recently, a blood sample from a newborn male with no apparent dysmorphic features was sent to the Mayo Clinic Cytogenet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d66e697bbb762375c59b737064c9fbe2
https://doi.org/10.1016/j.cancergen.2015.05.003
https://doi.org/10.1016/j.cancergen.2015.05.003